Chemoinformaics analysis of trans-caffeic-acid
| Molecular Weight | 136.15 | nRot | 2 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 14 |
| Exact Molecular Weight | 136.052 | nRing | 1 |
| Solubility: LogS | -3.745 | nHRing | 0 |
| Solubility: LogP | 3.838 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 20.2983 |
| nHD | 1 | BPOL | 8.89366 |
| QED | 0.662 |
| Synth | 2.116 |
| Natural Product Likeliness | 0.561 |
| NR-PPAR-gamma | 0.878 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -4.924 |
| MDCK | 0.0000146 |
| BBB | 0.29 |
| PPB | 1.00573 |
| VDSS | 0.519 |
| FU | 0.00673394 |
| CYP1A2-inh | 0.984 |
| CYP1A2-sub | 0.791 |
| CYP2c19-inh | 0.823 |
| CYP2c19-sub | 0.086 |
| CYP2c9-inh | 0.802 |
| CYP2c9-sub | 0.928 |
| CYP2d6-inh | 0.851 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.801 |
| CYP3a4-sub | 0.173 |
| CL | 9.716 |
| T12 | 0.696 |
| hERG | 0.088 |
| Ames | 0.843 |
| ROA | 0.663 |
| SkinSen | 0.938 |
| Carcinogencity | 0.539 |
| EI | 0.976 |
| Respiratory | 0.712 |
| NR-Aromatase | 0.657 |
| Antiviral | No |
| Prediction | 0.895946 |